Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Pair it with black pepper for better absorption
The cardiovascular safety and efficacy of tirzepatide in adults with T2D has been assessed in a large phase 3 clinical trial (SURPASS-CVOT) (Table 1) [88]
It should not be used by people who: Have a personal or family history of medullary thyroid carcinoma Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Have a known allergy or hypersensitivity to orforglipron or any of the components of the tablet Are pregnant, planning pregnancy in the near future, or breastfeeding Are already using another GLP-1 receptor agonist (combining them is not recommended) Caution is also advised in patients with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease such as gastroparesis, or significant kidney disease
By prioritizing quality care over shortcuts, it aligns with the future expectations of patients seeking medically supervised weight loss online
The ESSENCE study, published in 2025, found that Wegovy-induced weight loss significantly improved MASH pathology compared to placebo
US$ 28.43
US$ 25.30
US$ 29.09
